38 related articles for article (PubMed ID: 6285812)
21. [Development of beta-lactamase inhibitors].
Hyodo A; Higashitani F; Nishida K; Kunugita C; Unemi N
Nihon Rinsho; 1997 May; 55(5):1272-80. PubMed ID: 9155186
[TBL] [Abstract][Full Text] [Related]
22. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
Dajani A
J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
[TBL] [Abstract][Full Text] [Related]
23. Rational antibiotic therapy and the position of ampicillin/sulbactam.
Lode HM
Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
[TBL] [Abstract][Full Text] [Related]
24. Beta-lactamase production and the role of ampicillin/sulbactam.
Alpuche-Aranda CM
Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
[No Abstract] [Full Text] [Related]
25. Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infection.
Kerins DM
Am J Med Sci; 1991 Jun; 301(6):406-11. PubMed ID: 2039029
[No Abstract] [Full Text] [Related]
26. Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination.
Benson JM; Nahata MC
Drug Intell Clin Pharm; 1988; 22(7-8):534-41. PubMed ID: 3046887
[TBL] [Abstract][Full Text] [Related]
27. In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections.
Finegold SM
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S9-14; discussion S26-7. PubMed ID: 10526868
[TBL] [Abstract][Full Text] [Related]
28. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
Plouffe JF
Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
[TBL] [Abstract][Full Text] [Related]
29. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
30. Worldwide clinical experience with sultamicillin.
Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
[TBL] [Abstract][Full Text] [Related]
31. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Powell LL; Wilson SE
Surg Infect (Larchmt); 2000; 1(1):57-63. PubMed ID: 12594910
[TBL] [Abstract][Full Text] [Related]
32. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Friedel HA; Campoli-Richards DM; Goa KL
Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
[TBL] [Abstract][Full Text] [Related]
33. Ampicillin/sulbactam: current status in severe bacterial infections.
Rafailidis PI; Ioannidou EN; Falagas ME
Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]